Capillary Technologies India Limited (CAPILLARY) — Board Meeting | 4 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approved unaudited consolidated financial results for Q3 FY2026 and strategic acquisition of Kognitiv Solutions Inc.
🔄 What Changed
Revenue declined to ₹689.52 crores from ₹706.41 crores; profit before tax fell to ₹77.65 crores from ₹98.95 crores; ₹249.60 crore gain and ₹333.86 crore cyber-fraud loss recorded
🔮 What's Next
None
💡 Investor Takeaway
The company reported lower quarterly profits due to one-time gains and losses, while pursuing growth through acquisitions in North America.

The Board approved unaudited consolidated financial results for Q3 FY2026 ending June 30, 2026, following a Limited Review by Walker Chandiok & Co LLP that found no material misstatements. Revenue declined to ₹689.52 crores from ₹706.41 crores prior quarter, while profit before tax fell to ₹77.65 crores from ₹98.95 crores. The results include a ₹249.60 crore gain from a churn indemnity breach and a ₹333.86 crore cyber-fraud loss in a Czech subsidiary. The Board also approved a strategic acquisition of Kognitiv Solutions Inc. in Canada and the US to expand loyalty services, utilizing IPO proceeds for cloud infrastructure and R&D. Trading restrictions apply until August 11, 2026.

📄 View Original Announcement (PDF)

About Capillary Technologies India Limited (CAPILLARY)

Information Technology · IT - Software · Listed on NSE

Market Cap: ₹3,922.34 Cr P/E: 92.1 ROE: 4.1% ROCE: 4.4%

View full CAPILLARY stock details →

📡 Get AI alerts when CAPILLARY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CAPILLARY — Free

📊 More CAPILLARY filings

See all CAPILLARY filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CAPILLARY files new disclosures

Track CAPILLARY filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CAPILLARY — Free

Free account · 2 AI queries/day